Medycyna Wieku Rozwojowego

734
Bo˝enna Dembowska-Bagiƒska i wsp.
WNIOSKI
1. Cz´stoÊç wyst´powania poszczególnych grup nowotworów u m∏odzie˝y ró˝ni
si´ od wyst´pujàcych u pacjentów m∏odszych.
2. U m∏odzie˝y w wieku 15-19 lat w odró˝nieniu od dzieci m∏odszych obserwuje
si´ wyst´powanie raków.
3. Wyniki leczenia w grupie wiekowej 15-19 lat sà gorsze ni˝ u dzieci m∏odszych.
4. Istnieje koniecznoÊç optymalizacji leczenia nowotworów w tej grupie wieku.
PIÂMIENNICTWO
1. Smith M.A., Gurney J.G., Ries L.A.G.: Cancer among adolescents 15-19 years old. [w:] Ries
L.A.G., Smith M.A., Gurney J.G. editors, Cancer and survival among children and adolescents:
United States SEER Program NIH (Pub. No 99-4649); 1999 pp 157-164.
2. Birch J.M., Alston R.D., Kelsey A.M. i wsp.: Classification and incidence of cancer in adolescents
and young adults in England 1979-1997; Br. J. Cancer, 2002, 87, 1267-1274.
3. Bleyer W.A.: Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment,
survival and importance of clinical trials. Med. Pediatr. Oncol., 2002, 38, 1-10.
4. Coebergh J.W.W., Van Dijck J.A.M.M., Janssen-Heijnen M.L.G. i wsp.: The Netherlands
Cancer Registry; Childhood cancer in the Netherlands 1989-1997, Utrecht: Association of
Comprehensive Cancer Centers 2000.
5. Cotterill SJ, Parker L, Malcolm AJ i wsp.: Incidence and survival for cancer in children and
young adults in the North of England 1968-1995. Report from the Northern Region Young
Persons’ Malignant Disease Registry: Br. J. Cancer 2000, 83: 397-403.
6. Reaman G., Bonfiglio J., Krailo A. i wsp.: Cancer in adolescents and young adults; Cancer
1993, 71 (10 Suppl), 3206-3209.
7. Stiller C.: Epidemiology of cancer in adolescents. Med. Pediatr. Oncol., 2002, 3, 149-155.
8. Levin V.A., Leibel S.A., Gutin P.H.: Neoplasms of the central nervous system. [w:] De Vita
VT Jr, Hellman S, Rosenberg S.A., eds: Cancer: Principles and Practice of 9.
9. Oncology; 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2001, pp 2100-2160.
10. Mc Nally R.I.Q., Roman F., Cartwnigh R.A.: Leukemias and Lymphomas: time trends in
the UK 1984-1993 Cancer Causes Control., 1999, 10, 35-42.
11. Whyte F., Smith L.A.: A literature review of adolescence and cancer. Eur. J. Cancer 1997,
6, 137-146.
12. Constine L.S., Paidas C., Schwrtz C.L. i wsp.: Pediatric Solid Tumors. In Rubin P (ed): Clinical
Oncology, 8-th edition. Philadelphia, PA: WB Saunders 2000, 336-356.
13. Keneddy B.J., Loeb V., Peterson V. i wsp.: Survival in Hodgkin’s disease by age and stage.
Med. Padiatr. Oncol., 1992, 20:100.
14. Barr R.: On cancer control and the adolescent. Med. Pediatr. Oncol., 32, 404-410.
15. Bleyer W.A., Tajeda H., Murphy S.M. i wsp.: National cancer clinical trials Children have
equal success; adolescents do not. J. Adolesc. Health, 1997, 21, 366-373.
16. Nachman J., Sather H.N., Buckley J.D. i wsp.: Young adults 16-21 years of age at diagnosis
entered onto Children’s Cancer Group acute lymphoblastic leukemia and acute myeloblastic
leukemia protocols. Results of treatment. Cancer., 1993, 71, (10 Suppl): 3377-3385.
17. Collette L., Sylvester R.J., Stenning S.P. i wsp.: Impact of treating institution on survival
of patients with poor prognosis metastatic non semitomatous germ cell tumors. J. Natl. Cancer.
Inst., 1999, 91, 839-846.